Cargando…

Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients

BACKGROUND: Several studies show the relationship between chronic hyperglycemia and the appearance of macroangiopathy, microangiopathy and neuropathy. The major objective of this study was to investigate the serum lipids, renal function tests and inflammatory markersin type 2 diabetes patients. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjari, Mohammed, Bereksi, Karima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404330/
https://www.ncbi.nlm.nih.gov/pubmed/37551187
http://dx.doi.org/10.18502/ijph.v52i4.12441
_version_ 1785085275058208768
author Hadjari, Mohammed
Bereksi, Karima
author_facet Hadjari, Mohammed
Bereksi, Karima
author_sort Hadjari, Mohammed
collection PubMed
description BACKGROUND: Several studies show the relationship between chronic hyperglycemia and the appearance of macroangiopathy, microangiopathy and neuropathy. The major objective of this study was to investigate the serum lipids, renal function tests and inflammatory markersin type 2 diabetes patients. METHODS: The study lasted eight years between Feb-2013 and Mar-2021 (Mascara, Algeria). Overall,197 patients and 197 controls were selected during general medicine examinations; enzymatic and immunoturbidimetric colorimetric methods were used to determine the serum levels offasting glycaemia, total cholesterol, highdensity lipoprotein cholesterol, triglycerides, low-density lipoprotein cholesterol, fibrinogen, urea, acid uric, albumin and creatinine, C protein reactive; the glomerular filtration rate is calculated according to the MDRD equation; the glycatedhaemoglobin levels were determined by an ion-exchange resin separation method. RESULTS: Patients had 2.44 times higher fasting glycaemia, 1.71 times higher HbA1c, 1.23 times higher body mass index, 1.30 times higher waist circumference and 1.25times higher systolic blood pressure than control subjects; the findings of the present study also indicate that a significant differences between patients and controls were observed regarding triglycerides (P=0.008), LDL-cholesterol (P=0.011), HDL-cholesterol (P=0.009), urea (P=0.013), uric acid (P=0.015), creatinine (P=0.007), glomerular filtration rate (P=0.006), albumin (P=0.018), fibrinogen (P=0.023) and C protein reactive (P=0.019). CONCLUSION: All this metabolic disordercould facilitate the appearance of serious complications in future.
format Online
Article
Text
id pubmed-10404330
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-104043302023-08-07 Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients Hadjari, Mohammed Bereksi, Karima Iran J Public Health Original Article BACKGROUND: Several studies show the relationship between chronic hyperglycemia and the appearance of macroangiopathy, microangiopathy and neuropathy. The major objective of this study was to investigate the serum lipids, renal function tests and inflammatory markersin type 2 diabetes patients. METHODS: The study lasted eight years between Feb-2013 and Mar-2021 (Mascara, Algeria). Overall,197 patients and 197 controls were selected during general medicine examinations; enzymatic and immunoturbidimetric colorimetric methods were used to determine the serum levels offasting glycaemia, total cholesterol, highdensity lipoprotein cholesterol, triglycerides, low-density lipoprotein cholesterol, fibrinogen, urea, acid uric, albumin and creatinine, C protein reactive; the glomerular filtration rate is calculated according to the MDRD equation; the glycatedhaemoglobin levels were determined by an ion-exchange resin separation method. RESULTS: Patients had 2.44 times higher fasting glycaemia, 1.71 times higher HbA1c, 1.23 times higher body mass index, 1.30 times higher waist circumference and 1.25times higher systolic blood pressure than control subjects; the findings of the present study also indicate that a significant differences between patients and controls were observed regarding triglycerides (P=0.008), LDL-cholesterol (P=0.011), HDL-cholesterol (P=0.009), urea (P=0.013), uric acid (P=0.015), creatinine (P=0.007), glomerular filtration rate (P=0.006), albumin (P=0.018), fibrinogen (P=0.023) and C protein reactive (P=0.019). CONCLUSION: All this metabolic disordercould facilitate the appearance of serious complications in future. Tehran University of Medical Sciences 2023-04 /pmc/articles/PMC10404330/ /pubmed/37551187 http://dx.doi.org/10.18502/ijph.v52i4.12441 Text en Copyright © 2023 Hadjari et al. Published by Tehran University of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Hadjari, Mohammed
Bereksi, Karima
Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
title Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
title_full Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
title_fullStr Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
title_full_unstemmed Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
title_short Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
title_sort lipid profile, renal function tests and inflammatory markers in algerian type 2 diabetic patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404330/
https://www.ncbi.nlm.nih.gov/pubmed/37551187
http://dx.doi.org/10.18502/ijph.v52i4.12441
work_keys_str_mv AT hadjarimohammed lipidprofilerenalfunctiontestsandinflammatorymarkersinalgeriantype2diabeticpatients
AT bereksikarima lipidprofilerenalfunctiontestsandinflammatorymarkersinalgeriantype2diabeticpatients